| Whole body deletion of AMP-activated protein kinase {beta}2 reduces muscle AMPK activity and exercise capacity. | |
| | |
MedLine Citation:
|
PMID: 20855892 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
AMP-activated protein kinase (AMPK) β subunits (β1 and β2) provide scaffolds for binding α and γ subunits and contain a carbohydrate-binding module important for regulating enzyme activity. We generated C57Bl/6 mice with germline deletion of AMPK β2 (β2 KO) and examined AMPK expression and activity, exercise capacity, metabolic control during muscle contractions, aminoimidazole carboxamide ribonucleotide (AICAR) sensitivity, and susceptibility to obesity-induced insulin resistance. We find that β2 KO mice are viable and breed normally. β2 KO mice had a reduction in skeletal muscle AMPK α1 and α2 expression despite up-regulation of the β1 isoform. Heart AMPK α2 expression was also reduced but this did not affect resting AMPK α1 or α2 activities. AMPK α1 and α2 activities were not changed in liver, fat, or hypothalamus. AICAR-stimulated glucose uptake but not fatty acid oxidation was impaired in β2 KO mice. During treadmill running β2 KO mice had reduced maximal and endurance exercise capacity, which was associated with lower muscle and heart AMPK activity and reduced levels of muscle and liver glycogen. Reductions in exercise capacity of β2 KO mice were not due to lower muscle mitochondrial content or defects in contraction-stimulated glucose uptake or fatty acid oxidation. When challenged with a high-fat diet β2 KO mice gained more weight and were more susceptible to the development of hyperinsulinemia and glucose intolerance. In summary these data show that deletion of AMPK β2 reduces AMPK activity in skeletal muscle resulting in impaired exercise capacity and the worsening of diet-induced obesity and glucose intolerance. |
| | |
Authors:
|
Gregory R Steinberg; Hayley M O'Neill; Nicolas L Dzamko; Sandra Galic; Tim Naim; René Koopman; Sebastian B Jørgensen; Jane Honeyman; Kimberly Hewitt; Zhi-Ping Chen; Jonathan D Schertzer; John W Scott; Frank Koentgen; Gordon S Lynch; Matthew J Watt; Bryce J W van Denderen; Duncan J Campbell; Bruce E Kemp |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2010-09-20 |
Journal Detail:
|
Title: The Journal of biological chemistry Volume: 285 ISSN: 1083-351X ISO Abbreviation: J. Biol. Chem. Publication Date: 2010 Nov |
Date Detail:
|
Created Date: 2010-11-24 Completed Date: 2010-12-30 Revised Date: 2011-12-21 |
Medline Journal Info:
|
Nlm Unique ID: 2985121R Medline TA: J Biol Chem Country: United States |
Other Details:
|
Languages: eng Pagination: 37198-209 Citation Subset: IM |
Affiliation:
|
Department of Medicine, McMaster University, Hamilton, Ontario L8N 3Z5, Canada. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
AMP-Activated Protein Kinases
/
genetics,
metabolism* Animals Fatty Acids / metabolism Female Gene Deletion* Glucose / metabolism Male Mice / genetics, physiology* Mice, Inbred C57BL Mice, Knockout Muscle, Skeletal / enzymology*, physiology Physical Conditioning, Animal |
| Chemical | |
Reg. No./Substance:
|
0/Fatty Acids; 50-99-7/Glucose; EC 2.7.11.1/AMP-Activated Protein Kinases; EC 2.7.11.1/Prkab1 protein, mouse |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Identification of Ypk1 as a novel selective substrate for nitrogen starvation-triggered proteolysis ...
Next Document: Chronic ethanol consumption-induced pancreatic {beta}-cell dysfunction and apoptosis through glucoki...